GENFIT
Develops therapies and diagnostics for patients with rare and severe liver diseases.
GNFT | PA
Overview
Corporate Details
- ISIN(s):
- FR0004163111 (+2 more)
- LEI:
- 969500XPWN2DMZQA5X73
- Country:
- France
- Address:
- 885 AVENUE EUGENE AVINEE, 59120 LOOS
- Website:
- https://www.genfit.com
Description
GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-04-23 18:30 |
GENFIT : Mise à disposition du Document d’Enregistrement Universel 2020 et du R…
|
French | 130.9 KB | ||
| 2021-04-23 18:30 |
GENFIT: Publication of the 2020 Universal Registration Document and the 2020 An…
|
English | 130.9 KB | ||
| 2021-04-23 17:40 |
Document d'Enregistrement Universel 2020
|
French | 8.0 MB | ||
| 2021-04-22 22:10 |
GENFIT recrute Thomas Baetz en tant que Chief Financial Officer et nomme deux n…
|
French | 124.6 KB | ||
| 2021-04-22 22:10 |
GENFIT hires Thomas Baetz as Chief Financial Officer and adds two new members t…
|
English | 138.7 KB | ||
| 2021-04-01 22:10 |
GENFIT : Résultats financiers annuels 2020 et point sur les activités de la Soc…
|
French | 396.0 KB | ||
| 2021-04-01 22:10 |
GENFIT Reports Full-Year 2020 Financial Results and Provides Corporate Update
|
English | 408.5 KB | ||
| 2021-03-04 22:10 |
GENFIT appoints Jean-François Tiné to the Board of Directors
|
English | 137.9 KB | ||
| 2021-03-04 22:10 |
GENFIT : Jean-François Tiné rejoint le Conseil d’Administration
|
French | 120.9 KB | ||
| 2021-02-26 22:10 |
GENFIT : Chiffres d’Affaires et Position de Trésorerie au 31 décembre 2020
|
French | 195.4 KB | ||
| 2021-02-26 22:10 |
GENFIT: Revenues and Cash Position as of December 31, 2020
|
English | 443.1 KB | ||
| 2021-02-24 14:53 |
Franchissements de seuils
|
French | 346.7 KB | ||
| 2021-02-22 22:10 |
GENFIT: new market research data highlight potential of elafibranor in PBC
|
English | 207.6 KB | ||
| 2021-02-22 22:10 |
GENFIT : de nouvelles études de marché mettent en évidence le potentiel d’elafi…
|
French | 197.0 KB | ||
| 2021-02-10 22:10 |
GENFIT: 2021 Financial Calendar
|
English | 100.7 KB |
Automate Your Workflow. Get a real-time feed of all GENFIT filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENFIT
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENFIT via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-07-07 | N/A | Other | Buy | 5,300 | 19,488.10 EUR |
| 2023-07-06 | N/A | Other | Buy | 1,100 | 4,048.00 EUR |
| 2023-07-05 | N/A | Other | Buy | 10,000 | 37,061.00 EUR |
| 2023-07-03 | N/A | Other | Buy | 5,300 | 18,769.95 EUR |
Peer Companies
